Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-98,464
Closed -$858K 726
2025
Q1
$858K Sell
98,464
-10,753
-10% -$113K 0.01% 599
2024
Q4
$1.36M Buy
109,217
+8,411
+8% +$103K 0.01% 551
2024
Q3
$1.17M Sell
100,806
-8,489
-8% -$97.9K 0.01% 568
2024
Q2
$1.16M Buy
109,295
+20,958
+24% +$232K 0.01% 552
2024
Q1
$1.05M Buy
88,337
+544
+0.6% +$6.55K 0.01% 592
2023
Q4
$951K Buy
87,793
+27,785
+46% +$266K 0.01% 593
2023
Q3
$592K Hold
60,008
﹤0.01% 609
2023
Q2
$599K Sell
60,008
-4,317
-7% -$41.2K ﹤0.01% 668
2023
Q1
$570K Buy
64,325
+3,500
+6% +$38.8K ﹤0.01% 758
2022
Q4
$677K Sell
60,825
-9,675
-14% -$101K ﹤0.01% 769
2022
Q3
$601K Sell
70,500
-12,381
-15% -$122K ﹤0.01% 799
2022
Q2
$868K Buy
82,881
+3,738
+5% +$41K 0.01% 650
2022
Q1
$861K Sell
79,143
-188,409
-70% -$2.48M 0.01% 678
2021
Q4
$3.62M Sell
267,552
-4,685
-2% -$62.6K 0.02% 425
2021
Q3
$3.69M Sell
272,237
-3,603
-1% -$51.1K 0.03% 454
2021
Q2
$3.94M Buy
275,840
+19,290
+8% +$279K 0.03% 452
2021
Q1
$4.62M Hold
256,550
0.04% 383
2020
Q4
$4.81M Buy
+256,550
New +$4.18M 0.04% 392
2020
Q3
Sell
-50
Closed -$1K 829
2020
Q2
$1K Hold
50
﹤0.01% 800
2020
Q1
$1K Buy
+50
New +$958 ﹤0.01% 790

Other funds holding VTRS

Candriam SCA's VTRS Position: Q2 2025 in Review

Candriam SCA sold out of Viatris (VTRS) in Q2 2025, closing a stake of 98,464 shares — an estimated $858K sold.

Candriam SCA first reported a position in VTRS in Q1 2020 and held it in 20 quarters. The position peaked at $4.81M in Q4 2020. 975 funds tracked by Wall St. Rank hold VTRS as of Q2 2025.

  • Candriam SCA reported no remaining Viatris position as of Q2 2025 after selling out during the quarter.
  • Candriam SCA sold 98,464 Viatris shares in Q2 2025, an estimated $858K.
  • Candriam SCA first reported a position in Viatris in Q1 2020 and held it in 20 quarters.
  • Candriam SCA's Viatris position peaked at $4.81M in Q4 2020.
  • 975 funds tracked by Wall St. Rank held Viatris as of Q2 2025.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.